Purchases and Sales Made in Q4 2024 in Alnylam Pharmaceuticals, Inc. (ALNY)
This table provides information about the institutional ownership of Alnylam Pharmaceuticals, Inc. (ALNY) during Q4 2024. The information is specifically focused on institutions that hold shares of ALNYLAM PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 03, 2025
Q4 2024
|
Everence Capital Management Inc
|
BUY
|
- |
2.52KNew |
$585K - $757K
|
2.52K
$588K
|
|
|
Jan 06, 2025
Q4 2024
|
Nordea Investment Management Ab
Stockholm, V7 |
BUY
|
- |
637+ 6.67% |
$148K - $191K
|
10.2K
$2.38M
|
|
|
Jan 02, 2025
Q4 2024
|
Versant Capital Management, Inc
|
BUY
|
- |
83+ 77.57% |
$19.3K - $24.9K
|
190
$44.3K
|
|
|
Jan 02, 2025
Q4 2024
|
Gamma Investing LLC
Foster City, CA |
SELL
|
- |
-15- 2.71% |
$3.48K - $4.51K
|
539
$126K
|
|
|
Jan 03, 2025
Q4 2024
|
Central Pacific Bank Trust Division
Honolulu, HI |
SELL
|
- |
-20- 1.95% |
$4.65K - $6.01K
|
1.01K
$234K
|